These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18464177)

  • 1. [Intravitreal autologous plasmin without associated-vitrectomy. Pharmacological vitreolysis, a perfeccionated method using urokinase].
    Díaz-Llopis M; Udaondo P; Salom D; García-Delpech S; Romero FJ
    Arch Soc Esp Oftalmol; 2008 May; 83(5):291-2. PubMed ID: 18464177
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal autologous plasmin prepared by urokinase for vitreolysis: a pilot study.
    Maleki A; Tohidi-Zand SR; Amirizadeh N; Dehghan-Haghighi J; Zanjani H; Arish M; Salari AM; Mirhosseini SM; Abrishami M
    Eur J Ophthalmol; 2016; 26(1):67-70. PubMed ID: 26044374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autologous plasmin for intravitreal injection without associated vitrectomy: a simple preparation method with streptokinase].
    Udaondo P; Díaz-Llopis M; García-Delpech S; Cervera E; Salom D
    Arch Soc Esp Oftalmol; 2008 Mar; 83(3):153-4. PubMed ID: 18311672
    [No Abstract]   [Full Text] [Related]  

  • 4. Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery.
    Rizzo S; Pellegrini G; Benocci F; Belting C; Baicchi U; Vispi M
    Retina; 2006 Sep; 26(7):792-6. PubMed ID: 16963853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective of pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():1-6. PubMed ID: 19494646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progression of pharmacologic vitreolysis research].
    Zhou H; Ye J
    Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microplasmin-assisted vitrectomy.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():26-30. PubMed ID: 19494649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological vitrectomy.
    Tanaka M; Qui H
    Semin Ophthalmol; 2000 Mar; 15(1):51-61. PubMed ID: 10749315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic vitreolysis in diabetic retinopathy.
    El-Asrar AM; Al-Mezain HS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):406-9. PubMed ID: 20939804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Internal Limiting Membrane Specimens Following Intravitreal Injection of Ocriplasmin.
    Schumann RG; Wolf A; Mayer WJ; Compera D; Hagenau F; Ziada J; Kampik A; Haritoglou C
    Am J Ophthalmol; 2015 Oct; 160(4):767-78. PubMed ID: 26133247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological vitreolysis].
    Gandorfer A
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microplasmin for vitreomacular traction.
    Udaondo P; Diaz-Llopis M; Garcia-Delpech S; Salom D; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1859, 1859.e1; author reply 1859-60. PubMed ID: 20816250
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Men G; Peyman GA; Genaidy M; Kuo PC; Ghahramani F; Blake DA; Bezerra Y; Naaman G; Figueiredo E
    Retina; 2004 Apr; 24(2):199-209. PubMed ID: 15097878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of enzyme in vitreoretinal surgery].
    Czajka M; Pecold K
    Klin Oczna; 2002; 104(1):59-62. PubMed ID: 12046313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.
    de Smet MD; Gandorfer A; Stalmans P; Veckeneer M; Feron E; Pakola S; Kampik A
    Ophthalmology; 2009 Jul; 116(7):1349-55, 1355.e1-2. PubMed ID: 19447497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?
    Manousaridis K; Peter S; Mennel S
    Acta Ophthalmol; 2018 May; 96(3):e409-e411. PubMed ID: 28771974
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocriplasmin: a medical or surgical therapy?
    Duker JS; Moshfeghi AA
    Retina; 2013; 33(10):2001-2. PubMed ID: 24113274
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Gandorfer A; Kampik A
    Am J Ophthalmol; 2006 Apr; 141(4):784-5; author reply 785. PubMed ID: 16564844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.